Fulcrum Therapeutics, Inc.FULCNASDAQ
Loading
Income Quality Over TimeExpanding
Percentile Rank50
3Y CAGR-3.2%
5Y CAGR+1.1%
Year-over-Year Change
Quality of reported income
3Y CAGR
-3.2%/yr
vs +6.3%/yr prior
5Y CAGR
+1.1%/yr
Recent deceleration
Acceleration
-9.4pp
Decelerating
Percentile
P50
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.80 | +251.7% |
| 2024 | 0.23 | -75.6% |
| 2023 | 0.93 | +5.8% |
| 2022 | 0.88 | -9.0% |
| 2021 | 0.97 | +28.1% |
| 2020 | 0.76 | +58.6% |
| 2019 | 0.48 | -31.0% |
| 2018 | 0.69 | -20.8% |
| 2017 | 0.87 | - |